| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P356 | DOI | 10.1161/01.STR.0000080678.09344.8D |
| P698 | PubMed publication ID | 12843354 |
| P50 | author | Ale Algra | Q58370115 |
| Gabriël Rinkel | Q85898396 | ||
| P2093 | author name string | M J Ariesen | |
| S P Claus | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 2060-2065 | |
| P577 | publication date | 2003-07-03 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Risk factors for intracerebral hemorrhage in the general population: a systematic review | |
| P478 | volume | 34 |
| Q35111806 | 3-Hydroxy-3-methylglutaryl–Coenzyme A Reductase Inhibitors in the Treatment of Central Nervous System Diseases |
| Q31107693 | A prospective cohort study of stroke characteristics, care, and mortality in a hospital stroke registry in Vietnam |
| Q35486572 | Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study |
| Q37793839 | Advances in the management of intracerebral hemorrhage |
| Q40209836 | Age-Specific Vascular Risk Factor Profiles According to Stroke Subtype |
| Q93035554 | Age-period-cohort projection of trends in blood pressure and body mass index in children and adolescents in Hong Kong |
| Q36025116 | Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats |
| Q34119013 | Alcohol and acute ischemic stroke onset: the stroke onset study |
| Q37843772 | Alcohol consumption, blood pressure, and the risk of stroke |
| Q37304371 | Alcohol consumption: risks and benefits |
| Q35655474 | Alcohol intake and noncoronary cardiovascular diseases |
| Q30252500 | Alcohol use and risk of intracerebral hemorrhage |
| Q35611020 | An ABC for decision making |
| Q43839021 | Analysis of risk factors, localization and 30-day prognosis of intracerebral hemorrhage |
| Q38813195 | Animal models of spontaneous intracerebral hemorrhage |
| Q28221270 | Antiplatelet therapy for primary prevention in diabetes |
| Q45040270 | Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience. |
| Q48149969 | Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis. |
| Q51771300 | Aspirin for primary stroke prevention in elderly patients with vascular risk factors. |
| Q36567022 | Association Between Reduced Risk of Intracerebral Hemorrhage and Pelvic Inflammatory Disease |
| Q57224514 | Association between alanine aminotransferase and intracerebral hemorrhage in East Asian populations |
| Q27022672 | Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium |
| Q40291349 | Association between diabetes mellitus and incidence of intracerebral haemorrhage and case fatality rates: A retrospective population-based cohort study |
| Q39544827 | Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage. |
| Q64113798 | Association between intensive periodontal treatment and spontaneous intracerebral hemorrhage-a nationwide, population-based cohort study |
| Q48664098 | Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke: comparison with ischemic stroke |
| Q35896884 | Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts |
| Q48491698 | Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. |
| Q90777908 | Biopsy During Minimally Invasive Intracerebral Hemorrhage Clot Evacuation |
| Q50559223 | Blood Pressure Management After Intracerebral Hemorrhage. |
| Q41212396 | CD36 Gene Polymorphisms Are Associated with Intracerebral Hemorrhage Susceptibility in a Han Chinese Population. |
| Q37304873 | CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy |
| Q35449693 | Carotid intima-media thickness, electrocardiographic left ventricular hypertrophy, and incidence of intracerebral hemorrhage |
| Q39126853 | Cerebral Amyloid Angiopathy in Stroke Medicine. |
| Q34312007 | Cerebral amyloid angiopathy: A clinicopathological study of three cases |
| Q37435248 | Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations |
| Q40168154 | Characteristics of etiological diagnostic workup across the past 10 years in patients with spontaneous intracerebral hemorrhage in a large general hospital |
| Q36907362 | Childhood hemorrhagic stroke: an important but understudied problem |
| Q52599660 | Clinical and Radiographic Predictors of Intracerebral Hemorrhage Outcome. |
| Q81962702 | Clinical genetic issues in stroke |
| Q37106076 | Clinical review: Critical care management of spontaneous intracerebral hemorrhage |
| Q47162760 | Clinical study to assess the outcome in surgically managed patients of spontaneous intracerebral hemorrhage. |
| Q35174205 | Comparative Effects of α-, β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes |
| Q26753821 | Comparing Risk Factor Profiles between Intracerebral Hemorrhage and Ischemic Stroke in Chinese and White Populations: Systematic Review and Meta-Analysis |
| Q90401243 | Comparison of Genetic and Self-Identified Ancestry in Modeling Intracerebral Hemorrhage Risk |
| Q47373297 | Comparisons of Risk Factors for Intracerebral Hemorrhage versus Ischemic Stroke in Chinese Patients |
| Q91317808 | Computer-Assisted Analysis of Intracerebral Hemorrhage Shape and Density |
| Q44316111 | Cost effectiveness of apixaban versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation in Belgium |
| Q37052293 | Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin |
| Q39096950 | Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation. |
| Q58617834 | Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding |
| Q36657598 | Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial Fibrillation |
| Q39888518 | Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients |
| Q55312336 | Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation. |
| Q92965803 | Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data |
| Q37303759 | Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia |
| Q91812467 | Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK |
| Q28484289 | Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation |
| Q36258006 | Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences |
| Q36475213 | Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation |
| Q33924253 | Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation |
| Q40523358 | Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting |
| Q46304985 | Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation |
| Q44700478 | Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting |
| Q36940076 | Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US. |
| Q41678590 | Current management of spontaneous intracerebral haemorrhage |
| Q35114948 | Declining rates of fatal and nonfatal intracerebral hemorrhage: epidemiological trends in Australia |
| Q40888304 | Decreased risk of intracerebral hemorrhage among patients with milder allergic rhinitis |
| Q38163327 | Delayed ipsilateral parenchymal hemorrhage following treatment of intracranial aneurysms with flow diverter |
| Q53151768 | Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic. |
| Q39169261 | Diabetic aggravation of stroke and animal models. |
| Q55506964 | Differential Diagnosis and Prognostic Markers of Stroke. |
| Q38170028 | Do current animal models of intracerebral hemorrhage mirror the human pathology? |
| Q53671407 | Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase study. |
| Q34489975 | Does adhesive capsulitis of the shoulder increase the risk of stroke? A population-based propensity score-matched follow-up study |
| Q92434431 | Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis |
| Q37058755 | Drug insight: translating evidence on statin therapy into clinical benefits |
| Q36609053 | ECG changes of cardiac origin in elderly patients with traumatic brain injury |
| Q51819093 | Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis. |
| Q34553819 | Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort |
| Q55001278 | Endoscopic treatment of hypertensive intracerebral hemorrhage: A technical review. |
| Q30238502 | Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update |
| Q38007885 | Etiologies of intracerebral hematomas |
| Q37017398 | European research priorities for intracerebral haemorrhage |
| Q50238709 | Excessive work and risk of haemorrhagic stroke: a nationwide case-control study |
| Q35534164 | Experimental intracerebral hemorrhage: avoiding pitfalls in translational research |
| Q93092204 | Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects |
| Q41658536 | Factors affecting the outcome of surgical evacuation of spontaneous deep intra cerebral bleeds |
| Q31160762 | Factors associated with early deterioration after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis |
| Q44366068 | Frequency of stroke types at an emergency hospital in Natal, Brazil. |
| Q34797110 | Genetic Associations of Angiotensin-Converting Enzyme with Primary Intracerebral Hemorrhage: A Meta-analysis |
| Q60919616 | Genetic Polymorphisms Associated with Spontaneous Intracerebral Hemorrhage |
| Q22306361 | Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q50899846 | Haemostasis biomarkers and risk of intracerebral haemorrhage in the REasons for Geographic and Racial Differences in Stroke Study. |
| Q36914630 | Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke |
| Q37017126 | Hemostatic Markers and Long-Term Risk of Intracerebral Hemorrhage in Postmenopausal Women |
| Q36962739 | Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort |
| Q42117779 | Higher Rate of Intracerebral Hemorrhage in Hispanic Patients with Cerebral Cavernous Malformation |
| Q39252130 | Hyperbaric oxygen for experimental intracerebral haemorrhage: Systematic review and stratified meta-analysis |
| Q33834122 | Hyperemesis gravidarum and long-term mortality: a population-based cohort study |
| Q37364505 | Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J-RHYTHM Registry |
| Q40854299 | Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease |
| Q36993201 | Increased Risk of Intracranial Hemorrhage in Patients With Pregnancy-Induced Hypertension: A Nationwide Population-Based Retrospective Cohort Study |
| Q34571680 | Increased risk of hemorrhagic stroke in patients with migraine: a population-based cohort study |
| Q33689688 | Individual and population benefits of daily aspirin therapy: a proposal for personalizing national guidelines. |
| Q58698152 | Influence of Admission Blood Glucose in Predicting Outcome in Patients With Spontaneous Intracerebral Hematoma |
| Q34611350 | Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program. |
| Q36072031 | International epidemiology of intracerebral hemorrhage |
| Q39473342 | Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study |
| Q37238947 | Intracerebral hemorrhage and hypertension |
| Q26865843 | Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery |
| Q86924887 | Intracerebral hemorrhage: clinical overview and pathophysiologic concepts |
| Q48966082 | Intracerebral hemorrhage: effective therapy at last? |
| Q33413225 | Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol |
| Q26825331 | Intracranial hemorrhage |
| Q35152244 | Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage |
| Q36232280 | Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide |
| Q88543543 | Joint Effects of GWAS SNPs in Coagulation System Confer Risk to Hypertensive Intracerebral Hemorrhage |
| Q46704364 | Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. |
| Q33337507 | Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study |
| Q88717123 | Location of Thalamic Hemorrhage Impacts Prognosis |
| Q57320349 | Long term (13 years) prognosis after primary intracerebral haemorrhage: a prospective population based study of long term mortality, prognostic factors and causes of death |
| Q39144335 | Long-Term Risk of Dementia Among Survivors of Ischemic or Hemorrhagic Stroke |
| Q43068235 | Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer. |
| Q35820642 | Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control study |
| Q37603398 | Low-density lipoprotein and intracerebral hematoma expansion in daily alcohol users |
| Q53023586 | Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. |
| Q40478290 | Management of Primary Hypertensive Hemorrhage of the Brain. |
| Q26752952 | Management of intracerebral hemorrhage--use of statins |
| Q45028918 | Management of patients with intracerebral hemorrhages on Austrian Stroke Units: results of the GOG-BIQG Austrian Stroke Units Registry 2003-2007 |
| Q58114606 | Mass spectrometry based translational neuroinjury proteomics |
| Q38018892 | Medical versus surgical management of intracerebral hematomas |
| Q36141930 | Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes |
| Q30885468 | Migraine and hemorrhagic stroke: data from general practice |
| Q64898987 | Minimization of Intraparenchymal Hemorrhagic Stroke Size by Optimization of Serum Lipids. |
| Q36633878 | Modified Ideal Cardiovascular Health Status is Associated with Lower Prevalence of Stroke in Rural Northeast China |
| Q36013744 | Molecular mechanisms of age-related regulation of genes |
| Q57158373 | Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside |
| Q42370245 | Multiple Spontaneous Intracerebral Hematoma without Presenting Risk Factors. |
| Q89575447 | Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets |
| Q37598901 | New avenues for treatment of intracranial hemorrhage |
| Q36022209 | New era for management of primary hypertensive intracerebral hemorrhage |
| Q37086897 | Noncommunicable diseases: current status of major modifiable risk factors in Korea |
| Q41702102 | Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study |
| Q92609960 | Oligodendrocytes in intracerebral hemorrhage |
| Q37071949 | PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice |
| Q34451042 | Perioperative care of a patient with stroke |
| Q90473464 | Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy |
| Q42229962 | Predictors of risk of intracerebral haemorrhage in patients with a history of TIA or minor ischaemic stroke |
| Q48154248 | Previously undiagnosed risk factors and medication nonadherence are prevalent in young adults with first-ever stroke |
| Q50020974 | Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage. |
| Q38620315 | Prognostic factors of clinical endpoints in elderly patients with atrial fibrillation during a 2-year follow-up in China: An observational cohort study |
| Q37652936 | Progress in translational research on intracerebral hemorrhage: is there an end in sight? |
| Q84772802 | Public health strategies could reduce the global stroke epidemic |
| Q41115845 | Racial Associations with Hemorrhagic Presentation in Cerebral Arteriovenous Malformations. |
| Q24651019 | Racial differences in microbleed prevalence in primary intracerebral hemorrhage |
| Q47891553 | Resumption of Anticoagulation After Intracranial Hemorrhage |
| Q37509299 | Review of the SPARCL trial and its subanalyses |
| Q36421107 | Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study |
| Q35833463 | Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease. |
| Q22306374 | Risk Factors for Subarachnoid Hemorrhage: An Updated Systematic Review of Epidemiological Studies |
| Q91893932 | Risk Profile of Ischemic Stroke Caused by Small-Artery Occlusion vs. Deep Intracerebral Hemorrhage |
| Q37121900 | Risk factors for intracerebral hemorrhage: the REasons for geographic and racial differences in stroke (REGARDS) study |
| Q43012682 | Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study |
| Q50804557 | Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan. |
| Q51924177 | Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. |
| Q37017163 | Risk of Intracerebral Hemorrhage after Emergency Department Discharges for Hypertension |
| Q36838019 | Risk of Stroke in Patients With Spontaneous Pneumothorax: A Nationwide, Population-Based Study |
| Q38797922 | Risk of intracerebral hemorrhage in HIV/AIDS: a systematic review and meta-analysis |
| Q35103239 | Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease. |
| Q34715420 | Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study |
| Q55398440 | Should atrial fibrillation patients with hypertension as an additional risk factor of the CHA2DS2-VASc score receive oral anticoagulation? |
| Q26783036 | Silent New Brain Lesions: Innocent Bystander or Guilty Party? |
| Q46660409 | Smoking as a Crucial Independent Determinant of Stroke. |
| Q37164978 | Smoking as a crucial independent determinant of stroke |
| Q37160346 | Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study |
| Q35046463 | Spontaneous intra-cerebral hemorrhage: A retrospective study of risk factors and outcome in a Turkish population. |
| Q43586668 | Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. |
| Q36700829 | Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons |
| Q38999293 | Statin therapy and the risk of intracerebral haemorrhage: a nationwide observational study. |
| Q35126989 | Statin use and risk of haemorrhagic stroke in a community-based cohort of postmenopausal women: an observational study from the Women's Health Initiative |
| Q35170660 | Statin use following intracerebral hemorrhage: a decision analysis |
| Q64288554 | Statins and Risk of Intracerebral Haemorrhage in a Stroke-Free Population: A Nationwide Danish Propensity Score Matched Cohort Study |
| Q37907293 | Statins in hemorrhagic stroke |
| Q64985170 | Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage. |
| Q28395260 | Stroke epidemiology: advancing our understanding of disease mechanism and therapy |
| Q89599684 | Surgery for spontaneous intracerebral hemorrhage |
| Q48090578 | Surgical treatment for large spontaneous basal ganglia hemorrhage: retrospective analysis of 253 cases |
| Q92631353 | The Role of Urocortins in Intracerebral Hemorrhage |
| Q35562179 | The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke |
| Q28067962 | The critical care management of spontaneous intracranial hemorrhage: a contemporary review |
| Q36984606 | The effect of blood pressure on hematoma and perihematomal area in acute intracerebral hemorrhage |
| Q37245676 | The outcomes of spontaneous intracerebral hemorrhage in young adults - a clinical study |
| Q33728274 | The persisting burden of intracerebral haemorrhage: can effective treatments be found? |
| Q97544511 | The relationship between estrogen-induced phenotypic transformation and proliferation of vascular smooth muscle and hypertensive intracerebral hemorrhage |
| Q40142174 | The risk of stroke after prenatal exposure to famine |
| Q37861894 | The role of antiplatelets in hypertension and diabetes mellitus |
| Q33971455 | Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement |
| Q36972704 | Treatment and prevention of spontaneous intracerebral hemorrhage: comparison of EUSI and AHA/ASA recommendations |
| Q50420551 | Treatment of secondary brain injury by perturbing postsynaptic density protein-95-NMDA receptor interaction after intracerebral hemorrhage in rats. |
| Q35648063 | Treatment targets in intracerebral hemorrhage |
| Q37092111 | Trends in substance abuse preceding stroke among young adults: a population-based study |
| Q53291664 | Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. |
| Q38386638 | Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics |
| Q43848149 | Up-date in spontaneous cerebral hemorrhage |
| Q36471101 | Update on intracerebral haemorrhage |
| Q48507011 | Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management |
| Q35149252 | Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study |
| Q48905557 | Warfarin associated intracerebral hemorrhage in Hong Kong Chinese |
| Q87202122 | [Cost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain] |
| Q85563910 | [Intracranial hemorrhage: diagnosis, prognosis, acute treatment and secondary prophylaxis] |
| Q80103475 | [Spontaneous intracerebral hemorrhages] |
Search more.